Missed Dose Effect of Irbesartan in Hypertensive Patients and Cardiovascular Risk Profile Monitoring Under Irbesartan Treatment.

Trial Profile

Missed Dose Effect of Irbesartan in Hypertensive Patients and Cardiovascular Risk Profile Monitoring Under Irbesartan Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2009

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 04 Mar 2008 Status changed from in progress to completed.
    • 15 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top